Literature DB >> 3954322

Pattern of metastases in human breast carcinoma in relation to estrogen receptor status.

C Kamby, C Rose, H Iversen, N V Holm, K W Andersen, S M Thorpe.   

Abstract

The distribution of metastases at the first recurrence of breast cancer was studied in 57 estrogen receptor (ER) positive and in 23 ER negative patients, who constituted a subset of 460 patients with operable breast cancer. The pattern of metastases with respect to localization of metastases and the dominant site of first recurrence was similar in patients with ER positive and ER negative tumours. The recurrence-free survival (RFS) and the overall survival were associated with the ER status in the 460 patients. ER positive patients had both a significantly longer RFS (p = 0.0024) and survival (p = 0.0001) compared to ER negative patients. Survival after recurrence was prolonged in patients with soft tissue recurrences only, and the proportion of dead patients was highest in receptor negative patients with metastases to bone and viscera. In conclusion, we could not demonstrate that ER positive and negative tumours have a propensity for recurrence at specific sites.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954322

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Metastatic pattern and response to endocrine therapy in human breast cancer.

Authors:  C Kamby; C Rose
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

2.  Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading.

Authors:  G Blanco; K Holli; M Heikkinen; O P Kallioniemi; P Taskinen
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

3.  Relation between primary tumor FDG avidity and site of first distant metastasis in patients with breast cancer.

Authors:  Chae Hong Lim; Seung Hwan Moon; Young Seok Cho; Young-Hyuck Im; Yearn Seong Choe; Byung-Tae Kim; Kyung-Han Lee
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.